LUPIN
|
LUPIN Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.45 | -33.62 | 26.81 | -5.95 | 13.40 |
| CEPS(Rs) | 29.20 | 3.29 | 46.62 | 12.59 | 30.21 |
| DPS(Rs) | 4.00 | 4.00 | 6.50 | 6.00 | 5.00 |
| Book NAV/Share(Rs) | 270.67 | 263.84 | 300.06 | 272.01 | 298.87 |
| Tax Rate(%) | 37.52 | -9.99 | 26.75 | 152.81 | 63.02 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 6.05 | 0.73 | 9.08 | 7.87 | 9.68 |
| EBIT Margin(%) | 3.48 | -4.14 | 6.43 | 3.74 | 6.47 |
| Pre Tax Margin(%) | 2.52 | -4.62 | 5.93 | 2.53 | 5.32 |
| PAT Margin (%) | 1.57 | -5.09 | 4.34 | -1.34 | 1.97 |
| Cash Profit Margin (%) | 4.67 | 0.50 | 7.48 | 1.91 | 5.17 |
| Performance Ratios | |||||
| ROA(%) | 2.01 | -6.70 | 5.09 | -1.54 | 1.97 |
| ROE(%) | 3.68 | -11.79 | 9.47 | -3.09 | 3.88 |
| ROCE(%) | 6.06 | -7.11 | 9.71 | 5.45 | 7.97 |
| Asset Turnover(x) | 1.28 | 1.32 | 1.17 | 1.15 | 1.00 |
| Sales/Fixed Asset(x) | 1.67 | 1.93 | 1.96 | 2.00 | 1.79 |
| Working Capital/Sales(x) | 8.93 | 7.10 | 5.09 | 4.84 | 3.43 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.60 | 0.52 | 0.51 | 0.50 | 0.56 |
| Receivable days | 56.09 | 53.73 | 64.06 | 64.63 | 71.32 |
| Inventory Days | 58.53 | 53.64 | 48.75 | 44.49 | 51.72 |
| Payable days | 141.88 | 132.55 | 161.68 | 163.62 | 179.43 |
| Valuation Parameters | |||||
| PER(x) | 68.54 | - | 38.08 | - | 55.14 |
| PCE(x) | 22.19 | 227.04 | 21.90 | 46.84 | 24.46 |
| Price/Book(x) | 2.39 | 2.83 | 3.40 | 2.17 | 2.47 |
| Yield(%) | 0.62 | 0.54 | 0.64 | 1.02 | 0.68 |
| EV/Net Sales(x) | 1.95 | 2.23 | 3.26 | 1.99 | 2.79 |
| EV/Core EBITDA(x) | 17.33 | 85.46 | 18.26 | 10.77 | 14.15 |
| EV/EBIT(x) | 32.73 | -29.81 | 27.16 | 27.28 | 23.93 |
| EV/CE(x) | 1.42 | 1.69 | 2.11 | 1.23 | 1.50 |
| M Cap / Sales | 1.77 | 2.07 | 3.05 | 1.74 | 2.28 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 1.44 | 8.19 | -1.38 | 4.84 | -7.21 |
| Core EBITDA Growth(%) | 336.33 | -84.13 | -4.77 | -1.91 | -12.25 |
| EBIT Growth(%) | 180.59 | -167.66 | 62.21 | -34.55 | 128.91 |
| PAT Growth(%) | 129.66 | -222.92 | 407.07 | -176.75 | 104.46 |
| EPS Growth(%) | 128.11 | -225.39 | 550.89 | -144.36 | 141.19 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.34 | 0.32 | 0.35 | 0.51 | 0.63 |
| Current Ratio(x) | 1.34 | 1.51 | 1.66 | 1.67 | 2.26 |
| Quick Ratio(x) | 0.86 | 0.95 | 1.17 | 1.30 | 1.63 |
| Interest Cover(x) | 3.61 | -8.61 | 12.92 | 3.09 | 5.66 |
| Total Debt/Mcap(x) | 0.14 | 0.11 | 0.10 | 0.24 | 0.25 |
Compare Financial Ratios of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹70,514.5 Cr | 2.8% | 0% | 147.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 2.8% |
0% |
147.8% |
| SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses
